AlphaQuest LLC Sells 9,568 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

AlphaQuest LLC reduced its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 69.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,246 shares of the business services provider’s stock after selling 9,568 shares during the quarter. AlphaQuest LLC’s holdings in Huron Consulting Group were worth $528,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quest Partners LLC increased its holdings in shares of Huron Consulting Group by 131.9% in the third quarter. Quest Partners LLC now owns 13,814 shares of the business services provider’s stock valued at $1,502,000 after purchasing an additional 7,858 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Huron Consulting Group by 61.3% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,972 shares of the business services provider’s stock valued at $1,488,000 after purchasing an additional 4,550 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Huron Consulting Group by 29.1% in the third quarter. Wellington Management Group LLP now owns 538,290 shares of the business services provider’s stock valued at $58,512,000 after purchasing an additional 121,371 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of Huron Consulting Group by 20.5% in the third quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider’s stock valued at $42,306,000 after purchasing an additional 67,239 shares during the last quarter. Finally, Atom Investors LP acquired a new position in shares of Huron Consulting Group in the third quarter valued at $1,159,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Truist Financial upped their price objective on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, March 4th. Wedbush assumed coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They issued an “outperform” rating on the stock. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a research note on Monday. Barrington Research upped their price target on shares of Huron Consulting Group from $142.00 to $167.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Finally, Benchmark upped their price target on shares of Huron Consulting Group from $140.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, Huron Consulting Group currently has an average rating of “Buy” and an average price target of $155.50.

Huron Consulting Group Trading Down 1.0 %

Shares of Huron Consulting Group stock opened at $143.75 on Thursday. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 31.25 and a beta of 0.53. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. Huron Consulting Group Inc. has a 12-month low of $84.26 and a 12-month high of $153.85. The firm’s 50-day moving average price is $130.89 and its two-hundred day moving average price is $120.38.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.52 by $0.38. The firm had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. On average, analysts forecast that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director John Mccartney sold 500 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.65, for a total value of $62,325.00. Following the completion of the transaction, the director now owns 56,688 shares of the company’s stock, valued at approximately $7,066,159.20. This represents a 0.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James H. Roth sold 8,642 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $147.92, for a total transaction of $1,278,324.64. Following the completion of the transaction, the director now directly owns 73,563 shares of the company’s stock, valued at $10,881,438.96. This trade represents a 10.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 54,856 shares of company stock worth $7,958,682 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.